
Global pharmaceutical companies do not speak only the language of medicine.They speak a hybrid language — a mixture of science, business, law, logistics and technology. In international meetings, negotiations or strategy discussions, the vocabulary changes dramatically. Words that seem simple in everyday English acquire precise meanings connected to regulation, clinical trials, pricing strategy, market access […]